Li Li
Net worth: 786 M $ as of 31/05/2026
Net worth: 786 M $ as of 31/05/2026
Li Li is a businessperson who founded Shenzhen Hepalink Pharmaceutical Group Co., Ltd. and who has been at the head of 5 different companies. Presently, he holds the position of Chairman for Shenzhen Techdow Pharmaceutical Co., Ltd. and Chairman at Shenzhen Hepalink Pharmaceutical Group Co., Ltd., Chairman & Chief Executive Officer of Hepalink USA, Inc. and Chairman for Shenzhen Duopule Industrial Development Co., Ltd. (both are subsidiaries of Shenzhen Hepalink Pharmaceutical Group Co., Ltd.). He is also on the board of Cytovance Biologics, Inc. (former Chairman), Shenzhen Leren Technology Co. Ltd. and Urumqi Feilaishi Equity Investment Co. Ltd. Mr. Li received an undergraduate degree from Sichuan University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 30/09/2025 | 51,43,49,899 ( 41.24% ) | 755 M $ | 31/05/2026 | |
| 30/06/2025 | 7,78,04,710 ( 13.62% ) | 30 M $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD. | Founder | 21/04/1998 |
Shenzhen Leren Technology Co. Ltd.
Shenzhen Leren Technology Co. Ltd. Information Technology ServicesTechnology Services Engages in technology development | Director/Board Member | - |
Urumqi Feilaishi Equity Investment Co. Ltd. | Director/Board Member | - |
Shenzhen Techdow Pharmaceutical Co., Ltd. | Chairman | - |
Hepalink USA, Inc.
Hepalink USA, Inc. Pharmaceuticals: MajorHealth Technology Develops macromolecule biopharmaceutical products | Chief Executive Officer | - |
Shenzhen Duopule Industrial Development Co., Ltd.
Shenzhen Duopule Industrial Development Co., Ltd. Wholesale DistributorsDistribution Services Distributes biochemical products | Chairman | 13/01/2014 |
Cytovance Biologics, Inc.
Cytovance Biologics, Inc. BiotechnologyHealth Technology Manufactures therapeutic proteins and antibodies products | Director/Board Member | - |
Shenzhen Arimab Biopharmaceuticals Co., Ltd. | Chairman | - |
| Companies | Position | End |
|---|---|---|
| HIGHTIDE THERAPEUTICS, INC. | Director/Board Member | 02/02/2024 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 10 |
|---|---|
Cytovance Biologics, Inc.
Cytovance Biologics, Inc. BiotechnologyHealth Technology Manufactures therapeutic proteins and antibodies products | Health Technology |
Sichuan University
Sichuan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in production of heparin products | Health Technology |
Shenzhen Leren Technology Co. Ltd.
Shenzhen Leren Technology Co. Ltd. Information Technology ServicesTechnology Services Engages in technology development | Technology Services |
Urumqi Feilaishi Equity Investment Co. Ltd. | |
Shenzhen Techdow Pharmaceutical Co., Ltd. | |
Hepalink USA, Inc.
Hepalink USA, Inc. Pharmaceuticals: MajorHealth Technology Develops macromolecule biopharmaceutical products | Health Technology |
Shenzhen Duopule Industrial Development Co., Ltd.
Shenzhen Duopule Industrial Development Co., Ltd. Wholesale DistributorsDistribution Services Distributes biochemical products | Distribution Services |
Hightide Therapeutics, Inc.
Hightide Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of therapies for the treatment of metabolic and digestive diseases | Health Technology |
Shenzhen Arimab Biopharmaceuticals Co., Ltd. |
Select your edition
All financial news and data tailored to specific country editions